Pfizer’s parent company identifies some antiviral compounds to inhibit coronavirus: Report

03 Mar 2020 Evaluate

Pfizer’s parent company in the US has reportedly found some antiviral compounds that have the potential to inhibit coronavirus. The company is engaging with a third party to screen the compounds and it hopes that they would get the results from screening by the end of March. If any of the compounds are successful the company would start testing them by the end of the year.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

4363.00 39.85 (0.92%)
13-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5913.95
Cipla 1421.00
Zydus Lifesciences 993.40
Lupin 1684.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.